Clinical Trial Update: Molecular Imaging in Fabry Disease of the Heart

View source ↗

Summary

A University of Cambridge-led clinical trial is recruiting to study molecular imaging in Fabry disease of the heart (cardiac variant).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Snippet

Sponsor: University of Cambridge | Conditions: Fabry Disease, Cardiac Variant | Status: RECRUITING